Insider Transactions in Q2 2025 at Outlook Therapeutics, Inc. (OTLK)

OTLK Quotes by TradingView

Insider Transaction List (Q2 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
May 27 2025
Ghiath M. Sukhtian Director
BUY
Grant, award, or other acquisition
Indirect
4,285,714 +24.03%
$4,285,714 $1.4 P/Share

Track Institutional and Insider Activities on OTLK

Follow Outlook Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Insider Trading

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

News

Receive news related to Outlook Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLK